MCM
ZBH icon

McMillion Capital Management’s Zimmer Biomet ZBH Stock Holding History

McMillion Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-64
Closed -$6K – 294
2020
Q1 		$6K Buy
+64
New +$8.39K ﹤0.01% 230

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

McMillion Capital Management's ZBH Position: Q2 2020 in Review

McMillion Capital Management sold out of Zimmer Biomet (ZBH) in Q2 2020, closing a stake of 64 shares — an estimated $6K sold.

McMillion Capital Management first reported a position in ZBH in Q1 2020 and held it in 1 quarter. The position peaked at $6K in Q1 2020. 945 funds tracked by Wall St. Rank hold ZBH as of Q2 2020.

  • McMillion Capital Management reported no remaining Zimmer Biomet position as of Q2 2020 after selling out during the quarter.
  • McMillion Capital Management sold 64 Zimmer Biomet shares in Q2 2020, an estimated $6K.
  • McMillion Capital Management first reported a position in Zimmer Biomet in Q1 2020 and held it in 1 quarter.
  • McMillion Capital Management's Zimmer Biomet position peaked at $6K in Q1 2020.
  • 945 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2020.

Based on McMillion Capital Management's 13F filing for Q2 2020, filed 6 Aug 2020.